Ridgeway Jennifer L, Branda Megan E, Gravholt Derek, Brito Juan P, Hargraves Ian G, Hartasanchez Sandra A, Leppin Aaron L, Gomez Yvonne L, Mann Devin M, Nautiyal Vivek, Thomas Randal J, Behnken Emma M, Torres Roldan Victor D, Shah Nilay D, Khurana Charanjit S, Montori Victor M
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Knowledge and Evaluation Research Unit, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Implement Sci Commun. 2021 Apr 21;2(1):43. doi: 10.1186/s43058-021-00145-6.
The primary prevention of cardiovascular (CV) events is often less intense in persons at higher CV risk and vice versa. Clinical practice guidelines recommend that clinicians and patients use shared decision making (SDM) to arrive at an effective and feasible prevention plan that is congruent with each person's CV risk and informed preferences. However, SDM does not routinely happen in practice. This study aims to integrate into routine care an SDM decision tool (CV PREVENTION CHOICE) at three diverse healthcare systems in the USA and study strategies that foster its adoption and routine use.
This is a mixed method, hybrid type III stepped wedge cluster randomized study to estimate (a) the effectiveness of implementation strategies on SDM uptake and utilization and (b) the extent to which SDM results in prevention plans that are risk-congruent. Formative evaluation methods, including clinician and stakeholder interviews and surveys, will identify factors likely to impact feasibility, acceptability, and adoption of CV PREVENTION CHOICE as well as normalization of CV PREVENTION CHOICE in routine care. Implementation facilitation will be used to tailor implementation strategies to local needs, and implementation strategies will be systematically adjusted and tracked for assessment and refinement. Electronic health record data will be used to assess implementation and effectiveness outcomes, including CV PREVENTION CHOICE reach, adoption, implementation, maintenance, and effectiveness (measured as risk-concordant care plans). A sample of video-recorded clinical encounters and patient surveys will be used to assess fidelity. The study employs three theoretical approaches: a determinant framework that calls attention to categories of factors that may foster or inhibit implementation outcomes (the Consolidated Framework for Implementation Research), an implementation theory that guides explanation or understanding of causal influences on implementation outcomes (Normalization Process Theory), and an evaluation framework (RE-AIM).
By the project's end, we expect to have (a) identified the most effective implementation strategies to embed SDM in routine practice and (b) estimated the effectiveness of SDM to achieve feasible and risk-concordant CV prevention in primary care.
ClinicalTrials.gov, NCT04450914 . Posted June 30, 2020 TRIAL STATUS: This study received ethics approval on April 17, 2020. The current trial protocol is version 2 (approved February 17, 2021). The first subject had not yet been enrolled at the time of submission.
心血管(CV)事件的一级预防在心血管风险较高的人群中往往力度较小,反之亦然。临床实践指南建议临床医生和患者采用共同决策(SDM)来制定一个有效且可行的预防计划,该计划应与每个人的心血管风险及知情偏好相一致。然而,共同决策在实际中并非常规进行。本研究旨在将一种共同决策工具(CV预防选择)纳入美国三个不同医疗系统的常规护理中,并研究促进其采用和常规使用的策略。
这是一项混合方法、III型混合阶梯楔形整群随机研究,旨在估计(a)实施策略对共同决策采用和利用的有效性,以及(b)共同决策在多大程度上能产生与风险相符的预防计划。形成性评估方法,包括临床医生和利益相关者访谈及调查,将确定可能影响CV预防选择的可行性、可接受性和采用情况以及其在常规护理中常态化的因素。实施促进将用于根据当地需求调整实施策略,并且实施策略将被系统地调整和跟踪以进行评估和完善。电子健康记录数据将用于评估实施和有效性结果,包括CV预防选择的覆盖范围、采用情况、实施情况、维持情况和有效性(以风险一致的护理计划衡量)。视频记录的临床会诊样本和患者调查将用于评估保真度。该研究采用三种理论方法:一个决定因素框架,该框架关注可能促进或抑制实施结果的因素类别(实施研究综合框架);一种实施理论,用于指导对实施结果因果影响的解释或理解(常态化过程理论);以及一个评估框架(RE-AIM)。
到项目结束时,我们预计(a)已确定将共同决策融入常规实践的最有效实施策略,以及(b)估计了共同决策在初级保健中实现可行且与风险相符的心血管预防的有效性。
ClinicalTrials.gov,NCT04450914。2020年6月30日发布 试验状态:本研究于2020年4月17日获得伦理批准。当前试验方案为第2版(2021年2月17日批准)。提交时首个受试者尚未入组。